13th Mar 2023 15:20
LEI: 549300Q7EXQQH6KF7Z84
13 March 2023
RTW Venture Fund Limited
Update re Silicon Valley Bank exposure
RTW Venture Fund Limited (the "Company"), a London Stock Exchange-listed investment company focused on identifying transformative assets with high growth potential across the life sciences sector, provides an announcement on its exposure to Silicon Valley Bank ("SVB").
The Company and its investment manager, RTW Investments, LP, have no direct exposure to SVB.
No public companies in the portfolio have material exposure to SVB.
Four private core portfolio companies totaling 1.68% of NAV have some exposure to SVB. After US regulators moved to guarantee all SVB depositors last night, we do not envisage that this exposure will have a specific impact on the Company's NAV.
For Further Information
RTW Investments, LP +44 (0)20 7959 6361 Woody Stileman, Managing Director
Buchanan +44 (0)20 7466 5107 Charles Ryland
Henry Wilson
George Beale
About RTW Venture Fund Limited:
RTW Venture Fund Limited (LSE: RTW & RTWG) is an investment fund focused on identifying transformative assets with high growth potential across the life sciences sector. Driven by a long-term approach to support innovative businesses, RTW Venture Fund invests in companies developing next-generation therapies and technologies that can significantly improve patients' lives.
RTW Venture Fund Limited is managed by RTW Investments, LP, a leading healthcare-focused entrepreneurial investment firm with deep scientific expertise and a strong track record of supporting companies developing life-changing therapies.
Visit the RTW website at www.rtwfunds.com for more information.
***********
The information in this announcement may include forward-looking statements, which are based on the current expectations and projections about future events, and in certain cases can be identified by the use of terms such as "may", "will", "should", "expect", "anticipate", "project", "estimate", "intend", "continue", "target", "believe" (or the negatives thereon) or other variations thereon or comparable terminology. These forward-looking statements, as well as those included in any related materials, are subject to risks, uncertainties and assumptions about the Company and/or its underlying investments, including, among other things, the development of the applicable entity's business, trends in its operating industry, expected use of financing proceeds and future capital expenditures and acquisitions. In light of these risks, uncertainties and assumptions, the events in the forward-looking statements may not occur.
The information contained in this announcement is given at the date of its publication (unless otherwise marked). No reliance may be placed for any purpose whatsoever on the information or opinions contained in this announcement or on its completeness, accuracy or fairness.
***********
Related Shares:
Rtw Biotech